<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 23, 2000
---------------
VEREX LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C> <C>
Colorado 0-11232 84-0580695
---------------------------------------- -------------------------------------- --------------------------------------
(State or other jurisdiction of (Commission File No.) (IRS Employer ID No.)
incorporation)
</TABLE>
14 Inverness Drive East, D-100, Englewood, Colorado 80112
(Address of principal executive office) (Zip Code)
Registrant's telephone number, including area code: (303) 799-4499
(Not Applicable)
-----------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE> 2
VEREX LABORATORIES, INC.
FORM 8-K
CURRENT REPORT
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT
On June 23, 2000, Verex Laboratories, Inc. ("Registrant")
dismissed Ehrhardt, Keefe, Steiner & Hoffman P.C. ("EKS&H") as Registrant's
independent principal accountant and engaged the services of Balukoff Lindstrom
& Co., P.A. ("BL&Co."). EKS&H's report on the financial statements of the
Registrant for the year ended June 30, 1997 stated in its report that the
statements were prepared assuming that the Registrant will continue as a going
concern and the report contained the firm's opinion that the Registrant's
recurring operating losses and net capital deficiency raise substantial doubt
about its ability to continue as a going concern. No audit was completed for the
years ended June 30, 1998 and 1999.
The decision to dismiss EKS&H and engage BL&Co. was approved
by unanimous written consent of the Board of Directors of the Registrant on June
21, 2000.
There have been no disagreements between EKS&H and Registrant
on any matter of accounting principles or practices, financial statement
disclosure, or auditing scope or procedure. The term "disagreement" is utilized
in accordance with Item 304 of Regulation S-K.
Registrant provided EKS&H with a copy of this Current Report
on Form 8-K prior to its filing with the SEC and requested that EKS&H furnish it
with a letter, addressed to the SEC, indicating that it agrees with the
statements contained in this Current Report on Form 8-K and, if it does not
agree, indicating the statements with which it does not agree. Upon receipt of
such letter from EKS&G, Registrant shall file an amendment to this Current
Report on Form 8-K.
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Current Report on Form 8-K to be signed on its
behalf by the undersigned hereunto duly authorized.
Dated: June 23, 2000 VEREX LABORATORIES, INC.
By: /s/ Patrick Bols
-------------------------------
Patrick Bols
-------------------------------
Its: President
---------------------------
